Amalgam Rx Named to the 2022 CB Insights’ Digital Health 150 List
Amalgam Rx recognized for achievements in Digital Therapeutics NEW YORK--(BUSINESS WIRE)--#ClinicalDecisionSupport--CB Insights today named Amalgam Rx to its fourth-annual Digital Health 150, showcasing the 150 most promising private digital health co...